Literature DB >> 9727551

Evidence that macrophages in atherosclerotic lesions contain angiotensin II.

D D Potter1, C G Sobey, P K Tompkins, J D Rossen, D D Heistad.   

Abstract

BACKGROUND: We have reported that human mononuclear leukocytes contain large amounts of angiotensin II (Ang II). The goal of the present study was to test the hypothesis that Ang II is present in monocyte/macrophages in atherosclerotic lesions. METHODS AND
RESULTS: Segments of thoracic aorta and left circumflex coronary artery were obtained from 3 groups of cynomolgus monkeys: normal, atherosclerotic, and regression. Samples of human coronary arterial atherosclerotic lesions were obtained from directional atherectomy. Sections were stained for Ang II with 3 different polyclonal rabbit anti-human Ang II antisera. In aorta and coronary arteries from normal monkeys, there was no or minimal anti-Ang II staining in endothelial cells. All sections from atherosclerotic monkeys displayed discrete, localized regions of staining for Ang II in intima-media. Macrophages were present throughout the atherosclerotic intima-media, and anti-Ang II staining appeared to colocalize with macrophages. All human coronary atherectomy samples stained positive for Ang II and macrophages. Staining for both Ang II and macrophages was observed in vascular lesions from all 5 monkeys after regression of atherosclerosis, but staining was less extensive than in atherosclerotic blood vessels from monkeys.
CONCLUSIONS: These findings suggest that Ang II is present in atherosclerotic lesions in monkeys and humans, colocalizes with macrophages in intima-media of atherosclerotic vessels from monkeys, and decreases in lesions in monkeys with regression of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727551     DOI: 10.1161/01.cir.98.8.800

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Angiotensin II sustains brain inflammation in mice via TGF-beta.

Authors:  Tobias V Lanz; Zhaoqing Ding; Peggy P Ho; Jian Luo; Ankur N Agrawal; Hrishikesh Srinagesh; Robert Axtell; Hui Zhang; Michael Platten; Tony Wyss-Coray; Lawrence Steinman
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

Review 2.  Vitamin D receptor signaling in renal and cardiovascular protection.

Authors:  Yan Chun Li
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

Review 3.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

4.  T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats.

Authors:  Carmen De Miguel; Satarupa Das; Hayley Lund; David L Mattson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

5.  Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits.

Authors:  Shen Li; Yan-Ning Wang; Manabu Niimi; Bo Ning; Yajie Chen; Dedong Kang; Ziyun Wang; Qi Yu; Ahmed Bilal Waqar; Enqi Liu; Jifeng Zhang; Masashi Shiomi; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-17       Impact factor: 8.311

6.  Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?

Authors:  D M Shavelle
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

Review 7.  Is hypertension an immunologic disease?

Authors:  David G Harrison; Tomasz J Guzik; Jorg Goronzy; Cornelia Weyand
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

8.  Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.

Authors:  Daiana Weiss; Kenneth E Bernstein; Sebastian Fuchs; Jonathan Adams; Andreas Synetos; W Robert Taylor
Journal:  Atherosclerosis       Date:  2009-10-06       Impact factor: 5.162

9.  Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.

Authors:  Hong Lu; Debra L Rateri; David L Feldman; Richard J Charnigo; Akiyoshi Fukamizu; Junji Ishida; Elizabeth G Oesterling; Lisa A Cassis; Alan Daugherty
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.

Authors:  Deijanira Alves De Albuquerque; Vijay Saxena; David E Adams; Gregory P Boivin; Hermine I Brunner; David P Witte; Ram Raj Singh
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.